HAP, VAP, AND HCAP PATIENTS IN THE APEKS-NP CLINICAL TRIAL HAD SIMILAR GRAM-NEGATIVE MICROBIOLOGY: MORTALITY WAS DRIVEN BY VENTILATION STATUS